CLINICAL_TRIALS
research
· 2017-11-01
Clinical Trial Update: Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury
Summary
This clinical trial update describes investigating whether endothelial cell–specific molecule-1 (ESM-1) levels correlate with prognosis in patients with acute r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Jingyuan,Xu | Conditions: Evaluate the Correlation Between the Level of ESM-1 and the Prognosis of the Patients With ARDS | Status: UNKNOWN